aTyr Pharma (ATYR) Earnings Date & Reports

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ATYR is expected to report earnings to rise 14.71% to -19 cents per share on August 13

Q2'25

Est.

$-0.19

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 927.88K shares outstanding, the current market capitalization sits at 291.46M.

View a ticker or compare two or three

Compare

ATYR